abstract |
The present invention provides a composition comprising a compound represented by Formula 1 below, an isomer thereof or a pharmaceutically acceptable salt thereof, and a BTK inhibitor. The composition of the present invention exhibits an excellent therapeutic effect on lymphoid tumors. |